# Impact of Pharmacy Services on Gynaecology Chemotherapy Safety

> **NCT06826950** · — · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 629 (actual)

## Conditions studied

- Neoplasms
- Gynaecological Oncology

## Interventions

- **OTHER:** comprehensive pharmaceutical care
- **OTHER:** Routine pharmaceutical services

## Key facts

- **NCT ID:** NCT06826950
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-01-24
- **Target enrollment:** 629 (ACTUAL)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06826950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06826950, "Impact of Pharmacy Services on Gynaecology Chemotherapy Safety". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06826950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*